Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Marx

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Medicine and Science in Sports and Exercise|April 3, 2001
Low-volume circuit versus high-volume periodized resistance training in womenJ O Marx, N A Ratamess, B C Nindl, et al.
JCI Insight|January 19, 2023
Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heartXianghai Liao, Peter J Kennel, Bohao Liu, et al.
Nature Cardiovascular Research|June 6, 2022
Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium currentNourdine Chakouri, Sharen Rivas, Daniel Roybal, et al.
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
JCI Insight|April 26, 2019
Heterogeneity of the action potential duration is required for sustained atrial fibrillationUma Mahesh R Avula, Jeffrey Abrams, Alexander Katchman, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquee|May 18, 2000
Effects of exercise and alkalosis on serum insulin-like growth factor I and IGF-binding protein-3W J Kraemer, F S Harman, N H Vos, et al.
JCI Insight|September 2, 2020
Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channelsJeffrey Abrams, Daniel Roybal, Nourdine Chakouri, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
Lancet (London, England)|September 30, 2018
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trialGregg W Stone, Stephen G Ellis, Tommaso Gori, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Medicine and Science in Sports and Exercise|April 3, 2001
Low-volume circuit versus high-volume periodized resistance training in womenJ O Marx, N A Ratamess, B C Nindl, et al.
JCI Insight|January 19, 2023
Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heartXianghai Liao, Peter J Kennel, Bohao Liu, et al.
Nature Cardiovascular Research|June 6, 2022
Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium currentNourdine Chakouri, Sharen Rivas, Daniel Roybal, et al.
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
JCI Insight|April 26, 2019
Heterogeneity of the action potential duration is required for sustained atrial fibrillationUma Mahesh R Avula, Jeffrey Abrams, Alexander Katchman, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquee|May 18, 2000
Effects of exercise and alkalosis on serum insulin-like growth factor I and IGF-binding protein-3W J Kraemer, F S Harman, N H Vos, et al.
JCI Insight|September 2, 2020
Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channelsJeffrey Abrams, Daniel Roybal, Nourdine Chakouri, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
Lancet (London, England)|September 30, 2018
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trialGregg W Stone, Stephen G Ellis, Tommaso Gori, et al.
Pageof 17